BPC-157 vs Tirzepatide
Overview
BPC-157 is primarily a healing & recovery peptide, while Tirzepatide is used for weight management & metabolic.
This page compares BPC-157 and Tirzepatide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| BPC-157 | Tirzepatide | |
|---|---|---|
| Category | Healing & Recovery | Weight Management & Metabolic |
| Regulatory status (US) | Compounding (Rx) — Apr 2026 | FDA approved |
| Typical dosage | 250-500 mcg | 2.5-15 mg |
| Frequency | daily | weekly |
| Reported benefits | Accelerated wound healing, tendon and ligament repair, gut health improvement, reduced inflammation, neuroprotective effects | Enhanced weight loss, improved insulin sensitivity, better glycemic control, cardiovascular benefits |
| Reported side effects | Generally well-tolerated. Rare: injection site reactions, mild fatigue | Similar to semaglutide: GI disturbances, nausea, potential pancreatitis |
Key differences
Primary use. BPC-157 is categorised under Healing & Recovery, while Tirzepatide falls under Weight Management & Metabolic. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. BPC-157: not FDA-approved; compounding permitted with a prescription as of April 2026. Tirzepatide: FDA-approved.
Dosing. BPC-157 is typically dosed at 250-500 mcg (daily). Tirzepatide is typically dosed at 2.5-15 mg (weekly).
Can you stack them?
Some protocols combine peptides, but stacking BPC-157 and Tirzepatide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between BPC-157 and Tirzepatide?
- BPC-157 is primarily a healing & recovery peptide, while Tirzepatide is used for weight management & metabolic. BPC-157 is not FDA-approved; compounding permitted with a prescription (as of April 2026), whereas Tirzepatide is FDA-approved for one or more indications.
- What is BPC-157 used for?
- Healing & recovery, gut health.
- What is Tirzepatide used for?
- Dual GIP/GLP-1 agonist for weight loss.
- Can you take BPC-157 and Tirzepatide together?
- Some users combine peptides within a single protocol, but stacking BPC-157 and Tirzepatide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is BPC-157 or Tirzepatide FDA-approved?
- BPC-157 is not FDA-approved; compounding permitted with a prescription (as of April 2026). Tirzepatide is FDA-approved for one or more indications.
Read the full articles
- BPC-157 — full monograph: mechanism, research, dosing & references
- Tirzepatide — full monograph: mechanism, research, dosing & references